CRAIG WOO: Open Payments
NPI 1063131852 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,171 in 133 payments from 24 companies in 2025. Trend: 2023 $1,469 · 2024 $2,986 · 2025 $3,171
Food & beverage: $3,171
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $408 |
| GlaxoSmithKline, LLC. | 18 | $367 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $249 |
| ABBVIE INC. | 7 | $241 |
| Novartis Pharmaceuticals Corporation | 10 | $219 |
| Regeneron Healthcare Solutions, Inc. | 16 | $212 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $197 |
| GENZYME CORPORATION | 11 | $185 |
| Galderma Laboratories, L.P. | 1 | $158 |
| BioCryst US Sales Co., LLC | 5 | $123 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, RINVOQ, TRELEGY ELLIPTA, NEMLUVIO, CUVITRU, NUCALA.
Industry payments across CA — which companies pay providers there.
